Vivani Medical, Inc.
VANI
$1.22
-$0.025-2.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.51% | 8.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.80% | 1.50% | |||
| Operating Income | -13.80% | -1.50% | |||
| Income Before Tax | -13.36% | -4.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.36% | -4.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.36% | -4.17% | |||
| EBIT | -13.80% | -1.50% | |||
| EBITDA | -14.02% | -1.32% | |||
| EPS Basic | -13.35% | -0.95% | |||
| Normalized Basic EPS | -13.38% | -1.06% | |||
| EPS Diluted | -13.35% | -0.95% | |||
| Normalized Diluted EPS | -13.38% | -1.06% | |||
| Average Basic Shares Outstanding | 0.01% | 3.16% | |||
| Average Diluted Shares Outstanding | 0.01% | 3.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||